Total Valuation
Nunzia Pharmaceutical has a market cap or net worth of $43.46K. The enterprise value is $140.76K.
Market Cap$43.46K
Enterprise Value$140.76K
Share Statistics
Nunzia Pharmaceutical has 434,514,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding434,514,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nunzia Pharmaceutical’s return on equity (ROE) is 828.94 and return on invested capital (ROIC) is -2387913.98%.
Return on Equity (ROE)828.94
Return on Assets (ROA)-15.21K
Return on Invested Capital (ROIC)-2387913.98%
Return on Capital Employed (ROCE)828.90
Revenue Per Employee0.00
Profits Per Employee-19.52M
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nunzia Pharmaceutical is ―. Nunzia Pharmaceutical’s PEG ratio is 0.10.
PE Ratio―
PS Ratio0.00
PB Ratio-2.11K
Price to Fair Value-2.11K
Price to FCF-2.29K
Price to Operating Cash Flow-0.35
PEG Ratio0.10
Income Statement
In the last 12 months, Nunzia Pharmaceutical had revenue of 0.00 and earned -78.06M in profits. Earnings per share was -0.26.
Revenue0.00
Gross Profit0.00
Operating Income-78.06M
Pretax Income-78.06M
Net Income-78.06M
EBITDA-77.82M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was -277.92K and capital expenditures 0.00, giving a free cash flow of -277.92K billion.
Operating Cash Flow-277.92K
Free Cash Flow-277.92K
Free Cash Flow per Share>-0.01
Dividends & Yields
Nunzia Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta108.19
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Nunzia Pharmaceutical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Nunzia Pharmaceutical as a current ratio of <0.01, with Debt / Equity ratio of -103.47%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap<0.01
Net Debt to EBITDA>-0.01
Interest Coverage Ratio-41.92K
Taxes
In the past 12 months, Nunzia Pharmaceutical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nunzia Pharmaceutical EV to EBITDA ratio is -2.55, with an EV/FCF ratio of -2.29K.
EV to Sales0.00
EV to EBITDA-2.55
EV to Free Cash Flow-2.29K
EV to Operating Cash Flow-2.29K
Balance Sheet
Nunzia Pharmaceutical has $35.37K in cash and marketable securities with $183.34K in debt, giving a net cash position of -$147.97K billion.
Cash & Marketable Securities$35.37K
Total Debt$183.34K
Net Cash-$147.97K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Nunzia Pharmaceutical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―